Results for tag: "Indolent Lymphoma Drug"

Indolent lymphoma drugs are a type of medication used to treat non-Hodgkin's lymphoma, a type of cancer that affects the lymphatic system. These drugs are used to slow the progression of the disease and reduce the size of tumors. They are typically used in combination with other treatments such as chemotherapy and radiation therapy. Commonly used indolent lymphoma drugs include rituximab, bendamustine, and lenalidomide. These drugs are typically administered intravenously or orally. The indolent lymphoma drug market is highly competitive, with a number of companies offering various treatments. Major players in the market include Roche, Novartis, Merck, and Pfizer. Other companies such as AbbVie, Celgene, and Gilead Sciences are also active in the market. These companies are continuously developing new treatments and expanding their product portfolios to meet the needs of patients. Show Less Read more